alexa When Allergen Immunotherapy Perfectly Meets its Need: A
ISSN: 2155-6121

Journal of Allergy & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

When Allergen Immunotherapy Perfectly Meets its Need: A Case Report

Elisa Boni1, Cristoforo Incorvaia2*, Elena Makrì2, Donatella Preziosi3 and Marina Mauro3

1Allergy Unit, ASL Alessandria, Alessandria, Italy

2Cardiac/Pulmonary Rehabilitation, ASST Gaetano Pini/CTO, Milan, Italy

3Allergy Unit, Sant’Anna Hospital, ASST Lariana, Como, Italy

*Corresponding Author:
Cristoforo Incorvaia
Cardiac/Pulmonary Rehabilitation, ASST Gaetano Pini/CTO
Via Bignami, 20100 Milan, Italy
Fax: +390257003579
Tel: +390257993289
E-mail: [email protected]

Received date: May 31, 2017; Accepted date: June 05, 2017; Published date: June 12, 2017

Citation: Boni E, Incorvaia C, Makrì E, Preziosi D, Mauro M (2017) When Allergen Immunotherapy Perfectly Meets its Need: A Case Report. J Allergy Ther 8:259. doi: 10.4172/2155-6121.1000259

Copyright: © 2017 Boni E, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Seasonal, pollen-induced allergic rhinitis can be managed by symptomatic drug treatment, but only allergen immunotherapy (AIT) is able to work on the causes of allergy. Usually, the effectiveness of AIT is assessed by clinical criteria, though the ideal outcome is to lose the allergic sensitization to the administered allergen(s).

Here we report the case of a patient who after three years of AIT using a grass pollen extract containing Phleum pratense, Dactilys glomerata, Anthoxanthum odoratum, Poa pratensis and Lolium perenne but not Cynodon dactylon, to which the patient was also sensitized, developed a negative response to allergy tests to the administered allergens.

After 3 years of SCIT, the patient was free of both nose and lung symptoms during the grass pollen season and had negative results to the pollens included in the extract, while C. dactylon showed a decrease in respect to basal value but not a negative result.

The findings from this case show that AIT in optimal circumstances is able to achieve a complete tolerance to the administered allergen demonstrated by the development of negative results to the grass pollens contained in the extract used for the treatment. This confirms the recent definition of AIT as a treatment fulfilling the requirements of precision medicine.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version